UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 6, 2017
Accession Number:
Submission Type:
CIK: 0001626199
Company Name: Nivalis Therapeutics, Inc.
File Number: 333-218134